MSFT 419.78 0.4234% AAPL 225.36 0.5039% NVDA 149.123 2.6594% GOOGL 180.02 -0.183% GOOG 181.75 -0.1209% AMZN 206.566 -0.1325% META 583.0 -0.0292% AVGO 176.035 -1.607% TSLA 339.0599 -3.1257% TSM 191.05 -1.546% LLY 813.99 -2.2164% V 308.82 -0.4866% JPM 239.89 0.2507% UNH 615.58 -1.5466% NVO 105.956 -2.8729% WMT 84.965 0.8966% LVMUY 120.91 -5.0793% XOM 120.78 0.2573% LVMHF 605.0 -5.1263% MA 529.85 -0.0509%

Vertex Pharmaceuticals Inc

Healthcare US VRTX

499.31USD
-2.41(0.48%)

Last update at 2024-11-12T16:47:00Z

Day Range

498.67508.04
LowHigh

52 Week Range

320.01457.66
LowHigh

Fundamentals

  • Previous Close 501.72
  • Market Cap115318.72M
  • Volume201025
  • P/E Ratio29.67
  • Dividend Yield-%
  • EBITDA4583.70M
  • Revenue TTM10185.00M
  • Revenue Per Share TTM39.49
  • Gross Profit TTM 5323.10M
  • Diluted EPS TTM15.06

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 4232.40M 2730.40M 3116.80M 1394.92M 600.24M
Minority interest - - 0.00000M 0.00000M -9.79300M
Net income 3322.00M 2342.10M 2711.65M 1176.81M 2096.90M
Selling general administrative 887.20M 840.10M 770.46M 658.50M 557.62M
Selling and marketing expenses - - - - -
Gross profit 7850.40M 6670.20M 5469.38M 3615.06M 2638.06M
Reconciled depreciation 148.30M 125.60M 109.52M 106.94M 72.42M
Ebit 4307.40M 2782.10M 2856.29M 1197.57M 590.76M
Ebitda 4345.20M 2788.80M 3188.05M 1457.88M 663.18M
Depreciation and amortization 37.80M 6.70M 331.76M 260.31M 72.42M
Non operating income net other -20.20000M 9.80M 318.66M 255.85M -0.79000M
Operating income 4307.40M 2782.10M 2856.29M 1197.57M 635.15M
Other operating expenses 4565.30M 4795.40M 3336.29M 2960.80M 2383.63M
Interest expense 54.80M 61.50M 58.15M 58.50M 34.12M
Tax provision 910.40M 388.30M 405.15M 218.11M -1486.86200M
Interest income 144.60M 4.90M 22.24M 63.68M 33.50M
Net interest income 89.80M -56.60000M -35.91200M 5.18M -34.11900M
Extraordinary items - - - - 1560.00M
Non recurring 115.50M - - - 28.82M
Other items - - - - -
Income tax expense 910.40M 388.30M 405.15M 218.11M -1486.86200M
Total revenue 8930.70M 7574.40M 6205.68M 4162.82M 3047.60M
Total operating expenses 3485.00M 3891.20M 2599.99M 2413.04M 1974.09M
Cost of revenue 1080.30M 904.20M 736.30M 547.76M 409.54M
Total other income expense net -75.00000M -51.70000M 260.51M 197.35M -29.60600M
Discontinued operations - - - - -
Net income from continuing ops 3322.00M 2342.10M 2711.65M 1176.81M 2087.10M
Net income applicable to common shares 3322.00M 2342.10M 2711.65M 1176.81M 2096.90M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 22730.20M 18150.90M 13432.50M 11751.81M 8318.47M
Intangible assets 839.90M 603.60M 400.00M 400.00M 400.00M
Earning assets - - - - -
Other current assets 620.50M 74.40M 187.20M 308.35M 213.51M
Total liab 5149.80M 4238.20M 3332.50M 3064.99M 2233.22M
Total stockholder equity 17580.40M 13912.70M 10100.00M 8686.82M 6085.24M